ESMO Open shared a post on X:
“Multicenter analysis of high-dose chemotherapy regimens for the treatment of pts with refractory or recurrent GCTs in ESMO Open.
111 pts retrospectively analysed, similar results with CE vs TICE, potential benefit with TICE in higher risk disease.”
Title: Multicenter analysis of high-dose chemotherapy regimens for the treatment of patients with refractory or recurrent germ cell tumors
Authors: A. Chehrazi-Raffle, M. Zugman, H. Ebrahimi, M. O. Shodiya, E. Maldonado, T. Othman, S. Jaime-Casas, R. B. Carrillo, X. Li, S. K. Pal, A. Tripathi, A. Zhumkhawala, R. Hoeg, C. Oliai, R. L. Olin, T. B. Dorff, M. Mei
You can read the Full Article on ESMO Open.
More posts featuring ESMO Open.